I’m on the same page, the timeline isn’t as critical as getting the validation trial right. If that goes well, the rest should fall into place, including FDA approval and eventual commercialisation. Even if it takes a couple of years, it’ll be worth the wait.
You’re spot on about management too. They’ve played things smart, keeping things lean while pushing towards commercialisation. The idea of this tech becoming a new major imaging method alongside Ultrasound, CT, and MRI is exciting. Lots to look forward to!
EMV Price at posting:
$2.12 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)